8-K: Sycamore Partners Completes Walgreens Boots Alliance Acquisition

Walgreens Boots Alliance has completed its acquisition by Sycamore Partners, transitioning to a private entity with shareholders receiving cash and contingent rights.

Summary

• Walgreens Boots Alliance, Inc. (WBA) completed its previously announced merger on August 28, 2025, becoming a wholly-owned subsidiary of Blazing Star Parent, LLC, an affiliate of Sycamore Partners.
• WBA shareholders received $11.45 in cash per common stock share and one Divested Asset Proceed Right per share.
• Each Divested Asset Proceed Right entitles its holder to receive a share of 70% of the net proceeds from the future monetization of WBA's equity or debt interests in Village Practice Management Company Holdings, LLC (VillageMD), capped at $3.00 per right.
• The total cash consideration paid to WBA's equityholders at closing was approximately $8.25 billion.
• WBA's common stock and listed notes (3.600% notes due 2025 and 2.125% notes due 2026) ceased trading on The Nasdaq Stock Market LLC prior to the opening of trading on August 28, 2025, and will be delisted.
• All outstanding amounts and obligations under the Company's Three-Year Revolving Credit Agreement (dated August 9, 2023), Five-Year Revolving Credit Agreement (dated June 17, 2022), and Receivables Financing Agreement (dated April 24, 2025) were repaid, and related commitments and security interests were terminated.
• A tender offer and consent solicitation for various series of notes (including 2025, 2026, 2029, 2030, 2034, 2044, 2046, 2050, and Walgreen Co.'s 2042 notes) resulted in amendments to their respective indentures, eliminating certain covenants, events of default, and defeasance provisions.
• Notes not tendered or purchased in the tender offer, specifically the 2030, 2046, and 2050 notes, remain outstanding subject to the amended indentures, while other series were called for redemption and satisfied.

Sentiment

Score: 7

Explanation: The completion of the acquisition provides a clear resolution for shareholders, offering immediate cash value and potential future upside from divested assets. The transition to private ownership under Sycamore Partners, with a stated focus on core operations and customer experience, suggests a strategic path forward. The repayment of significant credit facilities is also a positive. However, the delisting ends public market access, and the contingent nature of the Divested Asset Proceed Rights introduces some uncertainty.

Positives

• Shareholders received a definitive cash payout of $11.45 per common stock share, providing immediate liquidity.
• Shareholders retain potential additional value through Divested Asset Proceed Rights, offering up to $3.00 per share from the future monetization of VillageMD interests.
• The company's transition to private ownership may enable more focused strategic execution and operational flexibility away from public market pressures.
• Significant revolving credit facilities and other debt obligations were fully repaid and terminated, strengthening the balance sheet under new ownership.

Negatives

• WBA's common stock and certain listed notes have ceased trading and will be delisted from Nasdaq, ending public ownership and trading access for investors.
• Existing public shareholders lose direct equity participation and voting rights in the ongoing business operations of Walgreens Boots Alliance.
• Certain protective covenants and events of default were eliminated from the indentures of various outstanding notes, potentially reducing protections for remaining noteholders.

Risks

• The value and timing of proceeds from the Divested Asset Proceed Rights are contingent on the future monetization of VillageMD interests, which includes Village Medical, Summit Health, and CityMD businesses, introducing uncertainty.
• The maximum payout from the Divested Asset Proceed Rights is capped at $3.00 per right, limiting potential upside from VillageMD's performance.

Future Outlook

Walgreens (Walgreen Co.) will operate as a private standalone company with a renewed focus on its core pharmacy and retail platform, stores, and customer experience. The Boots Group, Shields Health Solutions, CareCentrix, and VillageMD will also operate as separate standalone companies under private ownership, aiming to enhance customer experience and deepen trusted relationships.

Management Comments

• Stefan Kaluzny (Managing Director, Sycamore Partners): "Walgreens Boots Alliance, Inc., its companies, and its dedicated team members play an essential role in the communities they serve around the world. We look forward to partnering with the management teams at each company... As standalone companies under private ownership, they will build on their proud legacies to enhance the customer experience and deepen the trusted relationships they have earned with millions of customers around the world."
• Stefano Pessina: "This milestone begins a new chapter for Walgreens, The Boots Group and the other portfolio businesses. Our family has proudly supported these companies for decades, and we are pleased to continue that commitment alongside Sycamore. Together, we are united in our belief in the future of these organizations and the essential role they play in millions of lives each day."
• Mike Motz (Chief Executive Officer, Walgreen Co.): "Today represents an exciting new chapter and a turning point for Walgreens. As a private organization, alongside our dedicated team members, we are renewing our focus on our core pharmacy and retail platform, our stores and our customer experiencebuilding on the progress thats been made."
• Stefan Kaluzny (Managing Director, Sycamore Partners, regarding Walgreens): "We are pleased to have closed this momentous transaction with an outstanding brand that has been a cornerstone of American communities for nearly 125 years. Walgreens benefits millions of Americans, and I am confident that, enhanced by the flexibility of operating as a private standalone organization, it can move with certainty, speed and focus to deliver meaningful value to its customers."
• Stefano Pessina (regarding Walgreens): "Walgreens is an incredible brand, with loyal customers around the country. I believe strongly in the business and its significant impact on the communities it serves. My family and I are pleased to support its continued evolution as we embark on this next chapter. I want to thank the leadership team for stabilizing the business and providing a strong foundation upon which we will build to reach new heights. Walgreens has a very bright future in partnership with Sycamore."

Industry Context

The acquisition of Walgreens Boots Alliance by Sycamore Partners, a private equity firm, and its subsequent transition to a private entity, aligns with a broader industry trend of private equity firms taking public companies private. This strategy often aims to facilitate restructuring, operational optimization, and strategic shifts away from the quarterly pressures of public markets. The plan to operate various segments (Walgreens, Boots Group, Shields Health Solutions, CareCentrix, VillageMD) as separate standalone companies also reflects a focus on divesting or optimizing non-core assets and streamlining operations within the evolving healthcare retail and pharmacy sectors.

Management Changes

Corporate Governance

Related Party Transactions

• Mr. Stefano Pessina and certain entities affiliated with Mr. Pessina reinvested 100% of their interests in WBA as part of the equity funding for the acquisition by Sycamore Partners.

Stakeholder Impact

• Shareholders: Received a cash payment of $11.45 per share and contingent Divested Asset Proceed Rights, but lost their equity stake in a publicly traded company.
• Employees: Walgreens (Walgreen Co.) will operate as a private standalone company with new leadership, potentially leading to strategic and operational shifts.
• Noteholders: Holders of certain notes (2030, 2046, 2050) will continue to hold their notes under amended indentures with fewer protective covenants, while other note series were redeemed.
• Customers: Management statements indicate a renewed focus on core pharmacy and retail platforms and customer experience under private ownership.

Next Steps

• The Nasdaq Stock Market LLC will file a Form 25 with the SEC to remove the Company Common Stock and Listed Notes from listing and deregister them.
• The Company intends to file a Form 15 with the SEC to terminate registration and suspend its reporting obligations under the Exchange Act.
• Parent or its affiliates will proceed with the monetization of WBA's equity or debt interests in Village Practice Management Company Holdings, LLC, with proceeds distributed to holders of Divested Asset Proceed Rights.
• Walgreens, The Boots Group, Shields Health Solutions, CareCentrix, and VillageMD will operate as separate standalone companies under private ownership.

Key Dates

Keywords

Walgreens Boots Alliance, Sycamore Partners, Merger, Acquisition, Private Equity, Delisting, Healthcare Retail, Pharmacy, VillageMD, Debt Tender Offer, Corporate Governance, WBA